These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11864716)

  • 1. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes.
    Johansen EB; Aase H; Meyer A; Sagvolden T
    Behav Brain Res; 2002 Mar; 130(1-2):37-45. PubMed ID: 11864716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes.
    Sagvolden T; Johansen EB; Aase H; Russell VA
    Behav Brain Sci; 2005 Jun; 28(3):397-419; discussion 419-68. PubMed ID: 16209748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent, but not frequent, reinforcers produce more variable responding and deficient sustained attention in young children with attention-deficit/hyperactivity disorder (ADHD).
    Aase H; Sagvolden T
    J Child Psychol Psychiatry; 2006 May; 47(5):457-71. PubMed ID: 16671929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder.
    Sagvolden T; Aase H; Zeiner P; Berger D
    Behav Brain Res; 1998 Jul; 94(1):61-71. PubMed ID: 9708840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2011 Mar; 7():6. PubMed ID: 21450079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response disinhibition may be explained as an extinction deficit in an animal model of attention-deficit/hyperactivity disorder (ADHD).
    Johansen EB; Sagvolden T
    Behav Brain Res; 2004 Mar; 149(2):183-96. PubMed ID: 15129781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.
    Sergeant J
    Neurosci Biobehav Rev; 2000 Jan; 24(1):7-12. PubMed ID: 10654654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder.
    Berger DF; Sagvolden T
    Behav Brain Res; 1998 Jul; 94(1):73-82. PubMed ID: 9708841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology of ADHD.
    Tripp G; Wickens JR
    Neuropharmacology; 2009 Dec; 57(7-8):579-89. PubMed ID: 19627998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder.
    Halperin JM; Matier K; Bedi G; Sharma V; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):190-6. PubMed ID: 1564018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T; Xu T
    Behav Brain Funct; 2008 Jan; 4():3. PubMed ID: 18215285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2006 Dec; 2():41. PubMed ID: 17173664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
    Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD.
    Tripp G; Wickens JR
    J Child Psychol Psychiatry; 2008 Jul; 49(7):691-704. PubMed ID: 18081766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder and social dysfunctioning.
    Nijmeijer JS; Minderaa RB; Buitelaar JK; Mulligan A; Hartman CA; Hoekstra PJ
    Clin Psychol Rev; 2008 Apr; 28(4):692-708. PubMed ID: 18036711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of reinforcement and response-cost on a delayed response task in children with attention deficit hyperactivity disorder: a research note.
    Solanto MV
    J Child Psychol Psychiatry; 1990 Jul; 31(5):803-8. PubMed ID: 2398122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motives underlying smoking in college students with ADHD.
    Murphy KG; Flory K
    Am J Drug Alcohol Abuse; 2017 May; 43(3):350-359. PubMed ID: 27494646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological and endocrinological pattern in ADHD etiopathogenesis].
    Budziszewska B; Basta-Kaim A; Kubera M; Lasoń W
    Przegl Lek; 2010; 67(11):1200-4. PubMed ID: 21442976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.